BioAge Labs, Inc. ($BIOA)
Filing Information
| Accession Number | 0001210905-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 3, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
22,299
Total Value
$174,838.38
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Feb 2, 2026 | Exercise/Conversion | 5,433 | $4.11 | $22,329.63 | 5,433 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 2, 2026 | Exercise/Conversion | 2,000 | $6.57 | $13,140.00 | 7,433 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 2, 2026 | Sale | 7,433 | $18.75 | $139,368.75 | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Feb 2, 2026 | Exercise/Conversion | 5,433 | $0.00 | $0.00 | 10,870 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Feb 2, 2026 | Exercise/Conversion | 2,000 | $0.00 | $0.00 | 5,383 | Direct | โ | View Details |